基因与生活方式协同影响糖尿病视网膜病变发生
该多中心多族裔队列研究基于UK Biobank和广州糖尿病眼病研究,构建机器学习驱动的多基因风险评分,评估遗传风险与生活方式对糖尿病视网膜病变(DR)发生的独立及联合影响。结果显示高遗传风险者DR风险增加37%,不良生活方式者增加49%,二者并存风险翻倍以上;高遗传风险者保持有利生活方式可降低44%的DR风险。
要点
- 高遗传风险者DR风险较底风险者增加37%(HR 1.37)。
- 不良生活方式者DR风险较有利生活方式者增加49%(HR 1.49)。
核心结论
- 遗传风险与可改变的生活方式对DR发生具有独立且联合的影响。
- 尽管高遗传风险者从有利生活方式中获益最大,研究支持无论遗传背景如何均应进行普遍行为干预以预防DR。
研究设计与样本
- 基于182个文献来源的单核苷酸多态性构建机器学习驱动的DR多基因风险评分,并在两个多族裔前瞻性队列中验证。
- 生活方式依从性基于4项行为因素(不吸烟、理想体重控制、规律体力活动、健康睡眠)评分,分为有利(3-4项)、中等(2项)和不利(0-1项)。
- 采用Cox比例风险模型估计遗传风险与生活方式对 incident DR 的独立和联合关联。
主要发现
- 高遗传风险者发生DR的风险较低遗传风险者高37%(HR 1.37,95%CI 1.18-1.60,P<0.001),不受生活方式影响。
- 不利生活方式者DR风险较有利生活方式者高49%(HR 1.49,95%CI 1.34-1.65,P<0.001),不受遗传风险影响。
- 高遗传风险者中,有利生活方式与DR风险降低44%相关(HR 0.56,95%CI 0.42-0.75,P<0.001),标准化DR率从7.5%(95%CI 7.4-7.6)降至4.6%(95%CI 4.5-4.7)。
- 广州糖尿病眼病研究重复验证:中遗传风险(HR 1.47,95%CI 1.13-1.93,P=0.004)和高遗传风险(HR 1.68,95%CI 1.30-2.17,P<0.001)者DR风险显著高于低遗传风险者。
关键数值与推荐
- 遗传风险分组基于机器学习驱动的多基因风险评分,整合182个文献来源的单核苷酸多态性。
- 生活方式评分:有利=3-4项行为因素,中等=2项,不利=0-1项。
- 高遗传风险者有利生活方式使标准化DR率从7.5%(95%CI 7.4-7.6)降至4.6%(95%CI 4.5-4.7)。
临床怎么用
- 可将遗传风险与生活方式评估结合用于DR风险分层。
- 无论遗传背景如何,均建议推广不吸烟、体重控制、规律运动和健康睡眠等行为干预以预防DR。
- 高遗传风险者可能从生活方式干预中获益最大,应重点强化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop a machine learning (ML)-driven polygenic risk score (PRS) for diabetic retinopathy (DR) and evaluate the extent to which lifestyle may mitigate genetic risk. DESIGN: Multicenter, multiethnic cohort study. PARTICIPANTS: 9 1691 participants with DR-free prediabetes/diabetes from the UK Biobank (UKB); and 1119 participants with DR-free diabetes from the Guangzhou Diabetic Eye Study (GDES). METHODS: An ML-driven PRS for DR was constructed on an a priori basis by systematically integrating 182 literature-derived single nucleotide polymorphisms, which was subsequently applied to 2 multiethnic, prospective cohorts with genotyped data for unbiased stratification of genetic susceptibility. Lifestyle adherence was determined using a scoring system based on 4 behavioral factors (no smoking, optimal weight control, regular physical activity, and healthy sleep) that were categorized as favorable (3-4 factors), intermediate (2 factors), and unfavorable (0-1 factor). The independent and joint associations of genetic risk and lifestyle with incident DR were estimated using Cox proportional hazards models, with risk reduction analyses stratified by genetic risk category. MAIN OUTCOME MEASURES: Hazard ratios (HR) on incident DR. RESULTS: Participants at high genetic risk had a 37% higher risk of developing incident DR than those at low genetic risk, regardless of lifestyle (HR, 1.37, 95% confidence interval [CI], 1.18-1.60; P < 0.001). An unfavorable lifestyle was associated with a 49% higher risk than a favorable lifestyle, regardless of genetic risk (HR, 1.49, 95% CI, 1.34-1.65; P < 0.001). High genetic risk combined with an unfavorable lifestyle more than doubled the DR risk (HR, 2.09, 95% CI, 1.67-2.60; P < 0.001). Among participants at high genetic risk, a favorable lifestyle was associated with a 44% lower DR risk (HR, 0.56, 95% CI, 0.42-0.75; P < 0.001), corresponding to a reduction in the standardized DR rates from 7.5% (95% CI, 7.4-7.6) to 4.6% (95% CI, 4.5-4.7). The gene-lifestyle synergistic associations were confirmed by replication in the GDES: compared with participants at low genetic risk, those at intermediate (HR, 1.47, 95% CI, 1.13-1.93; P = 0.004) and high (HR, 1.68, 95% CI, 1.30-2.17; P < 0.001) genetic risk exhibited a significantly greater risk of incident DR. Adherence to a favorable lifestyle resulted in an relative risk reduction (RRR) of 47.4% and an absolute risk reduction (ARR) of 5380.0 standardized DR events for those at high genetic risk, and an RRR of 16.6% and an ARR of 988.3 standardized DR events for those at intermediate genetic risk, per 100,000 person‑years of follow‑up. CONCLUSIONS: Both genetic risk and modifiable lifestyles demonstrated independent and joint impacts on DR risk. Although risk reduction was greatest among those with high genetic risk, our findings support universal behavioral interventions for DR prevention, regardless of genetic background. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
引用
- Yang S, Xin Z, Liu B, et al. Gene-Lifestyle Synergy in Diabetic Retinopathy Development. Ophthalmology. 2026. PMID: 42055347. doi:10.1016/j.ophtha.2026.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。